( OTC-BB:BLFS )

News from biolife solutions, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 19, 2016, 06:00 ET BioLife Solutions and MNX Global Logistics Partner to Support ImmunoCellular Therapeutics with Cold Chain Logistics in ICT-107 Phase 3 Clinical Trial in Glioblastoma

 BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


May 18, 2016, 14:00 ET BioLife Solutions Appoints Jim Mathers as New Vice President of Sales

 BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


May 12, 2016, 16:05 ET BioLife Solutions Reports First Quarter 2016 Results

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic...


May 06, 2016, 06:30 ET BioLife Solutions to Report First Quarter 2016 Financial Results and Provide Business Update on May 12, 2016

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and...


May 04, 2016, 06:00 ET BioLife Solutions Names Roderick de Greef Chief Financial Officer & Secretary

 BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic...


May 02, 2016, 06:30 ET Seattle Business Magazine Names BioLife Solutions Washington State Manufacturer of the Year

 BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and...


Apr 26, 2016, 06:00 ET Biologistex LLC and MNX Global Logistics Partner to Offer Enhanced Cold Chain Logistics Services for Time and Temperature Sensitive Biologics, Vaccines & Cell Therapies

 Biologistex CCM, LLC, a joint venture of BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary...


Apr 04, 2016, 06:30 ET BioLife Solutions Names Cord Blood Industry Veteran Karen Foster Vice President of Operations

BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage...


Mar 14, 2016, 06:30 ET BioLife Solutions Provides Update on Customer Cell Therapy Clinical Trials and Development Programs

 BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic...


Mar 09, 2016, 06:00 ET BioLife Solutions to Present at 28th Annual ROTH Conference and 4th Annual ARM Cell & Gene Therapy Investor Day

 BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic...


Mar 07, 2016, 06:30 ET BioLife Solutions Names Roderick de Greef Interim Chief Financial Officer

 BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic...


Feb 25, 2016, 16:05 ET BioLife Solutions Reports 4th Quarter and Full Year 2015 Results

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Feb 22, 2016, 06:00 ET BioLife Solutions to Report Fourth Quarter 2015 Financial Results and Provide Business Update on February 25, 2016

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and...


Jan 27, 2016, 06:00 ET BioLife Solutions to Present at 18th Annual BIO CEO & Investors Conference

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Jan 25, 2016, 06:00 ET New Journal Articles Cite Expanded Use of BioLife Solutions Products in Clinical Cell Therapy Applications

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Jan 07, 2016, 06:00 ET BioLife Solutions Announces 2015 Biopreservation Media Revenue Growth of 30%

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Jan 06, 2016, 06:00 ET BioLife Solutions Distributor STEMCELL Technologies Will Test the evo™ Smart Shipper and Cloud Based biologistex™ Cold Chain Management App

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Nov 23, 2015, 06:00 ET BioLife Solutions Customer Capricor Therapeutics Provides Update on Heart Failure Cell Therapy Safety Data at American Heart Association Scientific Sessions

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Nov 16, 2015, 06:00 ET BioLife Solutions Makes Deloitte 2015 Technology Fast 500™

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Nov 12, 2015, 16:05 ET BioLife Solutions Reports 3rd Quarter 2015 Results

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Nov 02, 2015, 12:34 ET BioLife Solutions to Report Third Quarter 2015 Financial Results and Provide Business Update on November 12, 2015

 BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and...


Oct 22, 2015, 06:00 ET Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II Clinical Trial for Heart Failure

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Oct 19, 2015, 06:00 ET Kiadis Pharma Utilizes BioLife Solutions HypoThermosol® to Improve Viability and Shelf Life of Donor Leukocytes in Clinical Trial of ATIR101™ T Cell Therapy for Blood Cancers

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic...


Oct 05, 2015, 06:00 ET BioLife Solutions Reports Record Revenue and Provides Operations Update for Q3 2015

 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Sep 28, 2015, 06:00 ET BioLife Solutions to Present at Upcoming Investor Conferences

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic...